These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 8850749)
1. Measles lessons learned. Scott G Nurs Stand; 1996 Jul; 10(44):13. PubMed ID: 8850749 [No Abstract] [Full Text] [Related]
2. Rates of first measles-mumps-rubella immunisation in Wales (UK). Thomas DR; Salmon RL; King J Lancet; 1998 Jun; 351(9120):1927. PubMed ID: 9654262 [No Abstract] [Full Text] [Related]
3. A second dose of MMR vaccine for children in the United Kingdom. Commun Dis Rep CDR Wkly; 1996 Jul; 6(30):259. PubMed ID: 8755703 [No Abstract] [Full Text] [Related]
4. Targeted mailing of information to improve uptake of measles, mumps, and rubella vaccine: a randomised controlled trial. Mason BW; Donnelly PD Commun Dis Public Health; 2000 Mar; 3(1):67-8. PubMed ID: 10743326 [TBL] [Abstract][Full Text] [Related]
5. ACIP issues recommendations to eliminate measles, rubella and congenital rubella syndrome and to control mumps. Rose VL Am Fam Physician; 1998 Nov; 58(7):1682, 1685-6. PubMed ID: 9824963 [No Abstract] [Full Text] [Related]
6. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines. Heath TC; Burgess MA; O'Brien ED Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551 [No Abstract] [Full Text] [Related]
8. MMR vaccine coverage at 24 months stabilises in the UK. Commun Dis Rep CDR Wkly; 1999 Mar; 9(13):113, 116. PubMed ID: 10230112 [No Abstract] [Full Text] [Related]
9. Children who miss immunisation: implications for eliminating measles. Evans MR BMJ; 1995 May; 310(6991):1367-8. PubMed ID: 7787540 [No Abstract] [Full Text] [Related]
10. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region]. Salvadori P Ann Ig; 1998; 10(1):19-24. PubMed ID: 9616974 [No Abstract] [Full Text] [Related]
11. MMR vaccine--one year on. Walker D Practitioner; 1990 May; 234(1489):550-2. PubMed ID: 2392406 [No Abstract] [Full Text] [Related]
12. Measles, mumps, rubella and the GP. Kerrigan P Practitioner; 1988 Oct; 232(1456 ( Pt 2)):1121. PubMed ID: 3256857 [No Abstract] [Full Text] [Related]
13. The virtual elimination of rubella and mumps from the United States and the use of combined measles, mumps and rubella vaccines (MMR) to eliminate measles. Bart KJ; Orenstein WA; Hinman AR Dev Biol Stand; 1986; 65():45-52. PubMed ID: 3104117 [TBL] [Abstract][Full Text] [Related]
14. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). Watson JC; Hadler SC; Dykewicz CA; Reef S; Phillips L MMWR Recomm Rep; 1998 May; 47(RR-8):1-57. PubMed ID: 9639369 [TBL] [Abstract][Full Text] [Related]
15. [Certain problems with limits of immunity against measles, mumps and rubella]. Magdzik W Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387 [TBL] [Abstract][Full Text] [Related]
16. MMR vaccine: a new initiative. Miller C Practitioner; 1989 Jan; 233(1461):63-4, 66. PubMed ID: 2798287 [No Abstract] [Full Text] [Related]
17. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases. Böttiger M; Christenson B; Strandell A; Romanus V Dev Biol Stand; 1986; 65():37-43. PubMed ID: 3556776 [TBL] [Abstract][Full Text] [Related]